IRON THERAPY IN PATIENTS ON MAINTENENCE HAEMODIALYSIS

被引：0
|
作者：
EDWARDS, MS
PEGRUM, GD
CURTIS, JR
机构：
来源：
LANCET | 1970年 / 2卷 / 7671期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：491 / &
相关论文
共 50 条
  • [21] Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients
    Taylor, JE
    Peat, N
    Porter, C
    Morgan, AG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (06) : 1079 - 1083
  • [22] Indices of iron status in patients treated by chronic haemodialysis
    Zupan, IP
    Varl, J
    Kovac, D
    Cernelc, P
    Mlakar, U
    Andoljsek, D
    Pretnar, J
    Zver, S
    Modic, M
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2001, 442 (06): : R202 - R203
  • [23] Safety of intravenous injection of iron saccharate in haemodialysis patients
    SunderPlassmann, G
    Horl, WH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (09) : 1797 - 1802
  • [24] Indices of iron status in patients treated by chronic haemodialysis
    Irena Preložnik Zupan
    Janez Varl
    Damjan Kovač
    Peter Černelč
    Uroš Mlakar
    Dušan Andoljšek
    Jože Pretnar
    Samo Zver
    Mojca Modic
    Pflügers Archiv, 2001, 442 : r202 - r203
  • [25] Intensive iron therapy may be associated with the clinical expression of angina pectoris in patients undergoing chronic haemodialysis
    Reactions Weekly, 2006, 1127 (1) : 3 - 3
  • [26] Dosimetry For Haemodialysis Patients Undergoing A Radioiodine Therapy
    Kranert, W. T.
    Happel, C.
    Selkinski, I.
    Wright, D.
    Sauter, B.
    Middendorp, M.
    Diener, J.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S342 - S342
  • [27] Use of iv iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin
    Al-Hawas, F
    Abdalla, AH
    Popovich, W
    Mousa, DH
    Al-Sulaiman, MH
    Al-Khader, AA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (12) : 2801 - 2802
  • [28] Ferritin iron content in haemodialysis patients: Comparison with septic and hemochromatosis patients
    Spada, P. L.
    Rossi, C.
    Allmonti, A.
    Bocca, B.
    Cozza, V.
    Ricerca, B. M.
    Bocci, M. G.
    Vulpio, C.
    De Sole, P.
    CLINICAL BIOCHEMISTRY, 2008, 41 (12) : 997 - 1001
  • [29] Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients
    Canavese, C
    Bergamo, D
    Ciccone, G
    Burdese, M
    Maddalena, E
    Barbieri, S
    Thea, A
    Fop, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) : 1564 - 1570
  • [30] A randomized, open-label trial of iron isomaltoside 1000 (MonoferA®) compared with iron sucrose (VenoferA®) as maintenance therapy in haemodialysis patients
    Bhandari, Sunil
    Kalra, Philip A.
    Kothari, Jatin
    Ambuehl, Patrice M.
    Christensen, Jeppe H.
    Essaian, Ashot M.
    Thomsen, Lars L.
    Macdougall, Iain C.
    Coyne, Daniel W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (09) : 1577 - 1589
12345